jueves 14 de septiembre
Sala 1
07:45 - 08:10
Acreditaciones
08:10 - 10:30
Primer Simposio del Grupo Uruguayo de Linfoma (GULI)
LINFOMA DE HODGKIN
Actividad con sistema interactivo (votación) y traducción simultánea
Coordinadoras:
Dra.
Victoria Irigoin
Invitado:
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Presentadora:
Dra.
Isabel Moro
Panelistas:
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
10:30 - 11:00
Intervalo para café
11:00 - 12:00
Primer Simposio del Grupo Uruguayo de Linfoma (GULI)
LINFOMA DE HODGKIN
Actividad con sistema interactivo (votación) y traducción simultánea
Presentadora:
Dra.
Virginia Bradvica
Presentadora:
Dra.
Virginia Lema
Panelistas:
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
12:00 - 13:20
Almuerzo con el experto
Experto:
Dr.
Armando López Guillermo
(España)
[cv]
Dr.
Armando López Guillermo
- España
Curriculum Vitae:
Doctor en Medicina y Cirugía por la Universidad de Barcelona, especialista en Hematología y Hemoterapia tras realizar la residencia en el Hospital Clínic de Barcelona
Research Fellow en el Departamento de Linfoma y Mieloma del MD Anderson Center, Houston, Texas, USA
Moderador:
Dr.
Pablo Muxi
Experta:
Dra.
Beatriz Grand
(Argentina)
[cv]
Dra.
Beatriz Grand
- Argentina
Curriculum Vitae:
Médica Hematóloga. Hospital Juan A Fernández. División Obstetricia. Doctor en Medicina y Docente Autorizado de Medicina Facultad de Medicina UBA.
Moderadora:
Dra.
Patricia Kollar
Experto:
Dr.
Enrique Ocio
(España)
[cv]
Dr.
Enrique Ocio
- España
Curriculum Vitae:
Jefe de Servicio de Hematología y Hemoterapia del Hospital Universitario Marqués de Valdecilla en Santander y responsable del grupo de Investigación “Neoplasias Hematológicas y Trasplante de Progenitores Hematopoyéticos” en el Instituto de Investigación Sanitaria IDIVAL. Asimismo, es Profesor Titular de Medicina de la Universidad de Cantabria.
Moderadora:
Dra.
Carolina Córdoba
Experto:
Dr.
John Kuruvilla
(Canada)
[cv]
Dr.
John Kuruvilla
- Canada
Curriculum Vitae:
Dr. John Kuruvilla is an Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs and Co-Director of the Beyond Chemotherapy Program.
Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Moderadora:
Dra.
Victoria Irigoin
13:20 - 13:30
APERTURA - BIENVENIDA
XVII CONGRESO URUGUAYO DE HEMATOLOGÍA
13:30 - 15:00
Mesa
NEOPLASIAS LINFOPROLIFERATIVAS
Coordinadores:
Dra.
Virginia Bradvica
Invitado:
Dr.
Armando López Guillermo
(España)
[cv]
Dr.
Armando López Guillermo
- España
Curriculum Vitae:
Doctor en Medicina y Cirugía por la Universidad de Barcelona, especialista en Hematología y Hemoterapia tras realizar la residencia en el Hospital Clínic de Barcelona
Research Fellow en el Departamento de Linfoma y Mieloma del MD Anderson Center, Houston, Texas, USA
Dr.
Armando López Guillermo
(España)
[cv]
Dr.
Armando López Guillermo
- España
Curriculum Vitae:
Doctor en Medicina y Cirugía por la Universidad de Barcelona, especialista en Hematología y Hemoterapia tras realizar la residencia en el Hospital Clínic de Barcelona
Research Fellow en el Departamento de Linfoma y Mieloma del MD Anderson Center, Houston, Texas, USA
Dr.
Armando López Guillermo
(España)
[cv]
Dr.
Armando López Guillermo
- España
Curriculum Vitae:
Doctor en Medicina y Cirugía por la Universidad de Barcelona, especialista en Hematología y Hemoterapia tras realizar la residencia en el Hospital Clínic de Barcelona
Research Fellow en el Departamento de Linfoma y Mieloma del MD Anderson Center, Houston, Texas, USA
15:00 - 15:10
Pausa
15:10 - 16:10
Simposio JANSSEN
Mieloma Múltiple
Invitada:
Dra.
María Victoria Mateos
(España)
[cv]
Dra.
María Victoria Mateos
- España
Curriculum Vitae:
La Dra. María-Victoria Mateos, MD, PhD, es Jefa de la Unidad de Mieloma y ensayos clínicos en el Departamento de Hematología y Profesora de Medicina en la Universidad de Salamanca, España.
Presidenta de la Sociedad Nacional de Hematología desde octubre de 2022 por un mandato de cuatro años
Ejerce como coordinadora del GEM (Grupo Español de Mieloma), con implicancia directa en el diseño y desarrollo de ensayos clínicos.
También es miembro del IMWG (International MM Working Group), IMS (International MM Society), EHA y ASH.
Moderador:
Dr.
Pablo Muxi
16:10 - 16:30
Intervalo para café
16:30 - 18:00
Mesa
INMUNODEFICIENCIAS PRIMARIAS: “MAS ALLÁ DE LAS INFECCIONES”
Coordinadoras:
Dra.
Lilian Diaz F.
Panelistas:
Dra.
Alba Menyou
18:00 - 18:10
Pausa
18:10 - 19:40
Mesa
SÍNDROME ANTIFOSFOLIPIDO OBSTÉTRICO Y ENFERMEDAD TROMBOEMBOLICA EN EL EMBARAZO. MANEJO CLÍNICO BASADO EN LA EVIDENCIA
Coordinadoras:
Dra.
Maria Gabriela de Galvez
Invitada:
Dra.
Beatriz Grand
(Argentina)
[cv]
Dra.
Beatriz Grand
- Argentina
Curriculum Vitae:
Médica Hematóloga. Hospital Juan A Fernández. División Obstetricia. Doctor en Medicina y Docente Autorizado de Medicina Facultad de Medicina UBA.
Dra.
Beatriz Grand
(Argentina)
[cv]
Dra.
Beatriz Grand
- Argentina
Curriculum Vitae:
Médica Hematóloga. Hospital Juan A Fernández. División Obstetricia. Doctor en Medicina y Docente Autorizado de Medicina Facultad de Medicina UBA.
